Globus Medical

ISIN US3795772082

 | 

WKN A1J2LY

Marktkapitalisatie (in EUR)
10 178 M
Land
États-Unis
Sector
Santé
Dividendrendement
0,00%
 

Overzicht

Koers

Beschrijving

Globus Medical, Inc. est une entreprise de dispositifs médicaux qui développe et commercialise des solutions de soins de santé. L'entreprise développe des produits qui favorisent la guérison des patients souffrant de troubles musculo-squelettiques. Elle classe ses produits en deux catégories : Innovative Fusion et Disruptive Technology. Elle exerce ses activités dans les secteurs géographiques des États-Unis et de l'international. La société a été fondée par David C. Paul, David D. Davidar et Andrew Iott en mars 2003 et son siège social se trouve à Audubon, en Pennsylvanie.
Toon meer Toon minder
Santé Équipements de soins de santé Matériel médical général États-Unis

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 10 178 M
WPA, EUR 3,49
KBV 2,6
K/W 22,2
Dividendrendement 0,00%

Income statement (2025)

Omzet, EUR 2 605 M
Netto-inkomen, EUR 477 M
Winstmarge 18,30%

What ETF is Globus Medical in?

There are 3 ETFs which contain Globus Medical. All of these ETFs are listed in the table below. The ETF with the largest weighting of Globus Medical is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).
ETF Weging Investeringsfocus Fondsgrootte (in m EUR)
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0,01%
Equity
World
Social/Environmental
488
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0,02%
Equity
North America
Social/Environmental
24
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0,16%
Equity
United States
Small Cap
189

Prestaties

Rendementsoverzicht

YTD -2,45%
1 maand -0,46%
3 maanden -0,46%
6 maanden +46,38%
1 jaar +12,51%
3 jaar +43,94%
5 jaar -
Since inception +7,56%
2025 -5,35%
2024 +62,58%
2023 -30,14%
2022 +8,11%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).
Toon meer Toon minder

Risico-overzicht

Volatiliteit 1 jaar 43,36%
Volatiliteit 3 jaar 34,78%
Volatiliteit 5 jaar -
Rendement/Risico 1 jaar 0,29
Rendement/Risico 3 jaar 0,37
Rendement/Risico 5 jaar -
Maximaal waardedaling 1 jaar -37,68%
Maximaal waardedaling 3 jaar -50,53%
Maximaal waardedaling 5 jaar -
Maximaal waardedaling sinds aanvang -50,53%

Voortschrijdende volatiliteit over 1 jaar

— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.